A Phase I/ II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES). acbr. 2020;4(4):394-412. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/14778